India has ordered 300 million doses of an unapproved coronavirus vaccine amid a devastating second wave. The unnamed vaccine from Indian firm Biological E is in Phase 3 trials, and had showed “promising results” in the first two phases, the federal government said in a statement. The $206m order is the first India has signed…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions